bf/NASDAQ:INSM_icon.jpeg

NASDAQ:INSM

Insmed Incorporated

  • Stock

USD

Last Close

23.60

24/05 20:00

Market Cap

3.96B

Beta: 1.53

Volume Today

2.25M

Avg: 1.23M

PE Ratio

−5.60

PFCF: −7.74

  • locale

    usUnited States
  • market

    STOCKS
  • industry

    Biotechnology
  • website

    www.insmed.com
  • ipo date

    Jun 01, 2000

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptida...Show More

Earnings

Earnings per Share (Estimate*)

-1.5-1-0.52015-02-272017-02-232019-02-222021-02-252023-02-23

Revenue (Estimate*)

20M40M60M80M2015-02-272017-02-232019-02-222021-02-252023-02-23

*Estimate based on analyst consensus